Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- Swain, S.M.
- Kim, S.-B.
- Cortés, J.
- Ro, J.
- Semiglazov, V.
- Campone, M.
- Ciruelos, E.
- Ferrero, J.-M.
- Schneeweiss, A.
- Knott, A.
- Clark, E.
- Ross, G.
- Benyunes, M.C.
- Baselga, J.
ISSN: 1470-2045, 1474-5488
Argitalpen urtea: 2013
Alea: 14
Zenbakia: 6
Orrialdeak: 461-471
Mota: Artikulua